GSK BIO TARGETS INDIA FOR R&D

GlaxoSmithkline Biologicals, the vaccine business of pharma major GlaxoSmithKline (GSK), will make India a global hub for clinical research and development. Headquartered at Rixensart in Belgium, GSK Biologicals has lined-up global trial of four vaccines in India during 2005. The company is going to conduct clinical R&D process in India for its hi-tech vaccines for AIDS, dengue, malaria and TB. The company is now planning to conduct trials in India for nearly every product in the global research pipeline.

The Economic Times (http://economictimes.indiatimes.com/articleshow/985529.cms)